We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multidisciplinary Team Care in Pituitary Tumours.
- Authors
Marques, Pedro; Sagarribay, Amets; Tortosa, Francisco; Neto, Lia; Tavares Ferreira, Joana; Subtil, João; Palha, Ana; Dias, Daniela; Sapinho, Inês
- Abstract
Simple Summary: Pituitary tumours are slowly growing tumours of the pituitary gland, and they can cause damage due to the invasion or compression of surrounding tissues, such as the nerves responsible for vision, and/or due to altered hormone production. The treatment of pituitary tumours is complex and requires a wide range of medical specialists, including neurosurgeons, endocrinologists, neuropathologists, neuroradiologists, neuro-ophthalmologists, and otorhinolaryngologists, among others. Thus, optimal management of patients with pituitary tumours is best provided in the context of a dedicated multidisciplinary team with expertise in treating such conditions. The optimal care for patients with pituitary tumours is best provided in a multidisciplinary and collaborative environment, which requires the contribution of multiple medical specialties working together. The benefits and advantages of the pituitary multidisciplinary team (MDT) are broad, and all relevant international consensus and guidelines in the field recommend that patients with pituitary tumours should always be managed in a MDT. Endocrinologists and neurosurgeons are normally the leading specialties within the pituitary MDT, supported by many other specialties with significant contributions to the diagnosis and management of pituitary tumours, including neuropathology, neuroradiology, neuro-ophthalmology, and otorhinolaryngology, among others. Here, we review the literature concerning the concepts of Pituitary MDT/Pituitary Tumour Centre of Excellence (PTCOE) in terms of their mission, goals, benefits, structure, proposed models of function, and barriers, and we also provide the views of different specialists involved in our Pituitary MDT.
- Subjects
HORMONE metabolism; RISK assessment; NEUROSURGERY; OPHTHALMOLOGISTS; VISION disorders; CANCER invasiveness; DISEASE management; ENDOCRINOLOGISTS; PITUITARY tumors; NEURORADIOLOGY; HEALTH care teams; DISEASE risk factors
- Publication
Cancers, 2024, Vol 16, Issue 5, p950
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers16050950